Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Cancer Genome Atlas and Recurrence Risk Prediction of East Asian Breast Cancer: a Multicenter Collaborative Study

NCT04344496 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT04344496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04344496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Cancer Genome Atlas and Recurrence Risk Prediction of East Asian Breast Cancer: a Multicenter Collaborative Study
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Recruiting
Start date
October 18, 2018
Completion date
July 31, 2028
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer